EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells

Oncotarget

Volumn 6, Issue 12, 2015, Pages 9701-9717

  Lee, Ju Hee ^a   Moon, Ji Hong ^a   Kim, Sung Wook ^a   Jeong, Jae Kyo ^a   Nazim, Uddin M D ^a   Lee, You Jin ^a   Seol, Jae Won ^a   Park, Sang Youel ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Autophagy; EGCG; Neurotoxicity; Prion; Sirt1

Indexed keywords

AUTOPHAGY PROTEIN 5; CYTOCHROME C; EPIGALLOCATECHIN GALLATE; HISTONE DEACETYLASE 3; PRION PROTEIN; PROTEIN BAX; PROTEIN P62; SIRTINOL; SIRTUIN 1; SMALL INTERFERING RNA; BAX PROTEIN, HUMAN; CATECHIN; HISTONE DEACETYLASE; NEUROPROTECTIVE AGENT; PRION; RNA; SIRT1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INACTIVATION; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; CELL LINE; CHEMISTRY; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRION;

APOPTOSIS; AUTOPHAGY; BCL-2-ASSOCIATED X PROTEIN; CATECHIN; CELL LINE; HISTONE DEACETYLASES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEURONS; NEUROPROTECTION; NEUROPROTECTIVE AGENTS; PRIONS; RNA; RNA, SMALL INTERFERING; SIRTUIN 1;

EID: 84929591024     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3832     Document Type: Article

References (78)

1. Wickner RB, Edskes HK, Shewmaker F and Nakayashiki T. Prions of fungi: inherited structures and biological roles. Nat Rev Microbiol. 2007; 5:611-618.
2. Tuite MF and Serio TR. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol. 2010; 11:823-833.
3. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001; 24:519-550.
4. Lambert JD, Sang S, Hong J, Kwon SJ, Lee MJ, Ho CT and Yang CS. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab Dispos. 2006; 34:2111-2116.
5. Krasemann S, Neumann M, Szalay B, Stocking C and Glatzel M. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrPSc and prion infectivity. J Gen Virol. 2012.
6. Bergstrom AL, Cordes H, Zsurger N, Heegaard PM, Laursen H and Chabry J. Amidation and structure relaxation abolish the neurotoxicity of the prion peptide PrP106-126 in vivo and in vitro. J Biol Chem. 2005; 280:23114-23121.
7. Selvaggini C, De Gioia L, Cantu L, Ghibaudi E, Diomede L, Passerini F, Forloni G, Bugiani O, Tagliavini F and Salmona M. Molecular characteristics of a proteaseresistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochemical and biophysical research communications. 1993; 194:1380-1386.
8. Gong J, Jellali A, Forster V, Mutterer J, Dubus E, Altrock WD, Sahel JA, Rendon A and Picaud S. The toxicity of the PrP106-126 prion peptide on cultured photoreceptors correlates with the prion protein distribution in the mammalian and human retina. Am J Pathol. 2007; 170:1314-1324.
9. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O and Tagliavini F. Neurotoxicity of a prion protein fragment. Nature. 1993; 362:543-546.
10. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB and Lingappa VR. A transmembrane form of the prion protein in neurodegenerative disease. Science. 1998; 279:827-834.
11. Romeo L, Intrieri M, D'Agata V, Mangano NG, Oriani G, Ontario ML and Scapagnini G. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am Coll Nutr. 2009; 28 Suppl:492S-499S.
12. Mandel S, Weinreb O, Amit T and Youdim MB. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate:implications for neurodegenerative diseases. J Neurochem. 2004; 88:1555-1569.
13. Chao J, Lau WK, Huie MJ, Ho YS, Yu MS, Lai CS, Wang M, Yuen WH, Lam WH, Chan TH and Chang RC. A prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine. Neuroscience letters. 2010; 469:360-364.
14. Sano J, Inami S, Seimiya K, Ohba T, Sakai S, Takano T and Mizuno K. Effects of green tea intake on the development of coronary artery disease. Circ J. 2004; 68:665-670.
15. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr. 2007; 26(4):373S-388S.
16. Moyers SB and Kumar NB. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev. 2004; 62:204-211.
17. Boschmann M and Thielecke F. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr. 2007; 26:389S-395S.
18. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ and Montagnani M. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab. 2007; 292:E1378-1387.
19. Aktas O, Prozorovski T, Smorodchenko A, Savaskan NE, Lauster R, Kloetzel PM, Infante-Duarte C, Brocke S and Zipp F. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol. 2004; 173:5794-5800.
20. Schroeder EK, Kelsey NA, Doyle J, Breed E, Bouchard RJ, Loucks FA, Harbison RA and Linseman DA. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxidants & redox signaling. 2009; 11:469-480.
21. Hechler D, Nitsch R and Hendrix S. Green-fluorescentprotein-expressing mice as models for the study of axonal growth and regeneration in vitro. Brain Res Rev. 2006; 52:160-169.
22. Levine B and Klionsky DJ. Development by self-digestion:molecular mechanisms and biological functions of autophagy. Developmental cell. 2004; 6:463-477.
23. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. The EMBO journal. 2000; 19:5720-5728.
24. Tanida I, Minematsu-Ikeguchi N, Ueno T and Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005; 1:84-91.
25. Mizushima N, Yoshimori T and Levine B. Methods in mammalian autophagy research. Cell. 2010; 140:313-326.
26. Michan S and Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007; 404:1-13.
27. Pillarisetti S. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat Cardiovasc Drug Discov. 2008; 3:156-164.
28. Guarente L. Calorie restriction and SIR2 genes--towards a mechanism. Mech Ageing Dev. 2005; 126:923-928.
29. Haigis MC and Guarente LP. Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006; 20:2913-2921.
30. Yamamoto H, Schoonjans K and Auwerx J. Sirtuin functions in health and disease. Mol Endocrinol. 2007; 21:1745-1755.
31. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA and Tsai LH. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007; 26:3169-3179.
32. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P and Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006; 127:1109-1122.
33. Lan F, Cacicedo JM, Ruderman N and Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem. 2008; 283:27628-27635.
34. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K and Horio Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem. 2010; 285:8375-8382.
35. Danz ED, Skramsted J, Henry N, Bennett JA and Keller RS. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med. 2009; 46:1589-1597.
36. Dasgupta B and Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A. 2007; 104:7217-7222.
37. Ding DF, You N, Wu XM, Xu JR, Hu AP, Ye XL, Zhu Q, Jiang XQ, Miao H, Liu C and Lu YB. Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK. Am J Nephrol. 2010; 31:363-374.
38. Jeong JK, Moon MH, Lee YJ, Seol JW and Park SY. Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity. Neurobiol Aging. 2013; 34:146-156.
39. Queen BL and Tollefsbol TO. Polyphenols and aging. Curr Aging Sci. 2010; 3(1):34-42.
40. de Boer VC, de Goffau MC, Arts IC, Hollman PC and Keijer J. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech Ageing Dev. 2006; 127:618-627.
41. Ye Q, Ye L, Xu X, Huang B, Zhang X, Zhu Y and Chen X. Epigallocatechin-3-gallate suppresses 1-methyl-4-phenylpyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1alpha signaling pathway. BMC Complement Altern Med. 2012; 12:82.
42. Abib RT, Peres KC, Barbosa AM, Peres TV, Bernardes A, Zimmermann LM, Quincozes-Santos A, Fiedler HD, Leal RB, Farina M and Gottfried C. Epigallocatechin-3-gallate protects rat brain mitochondria against cadmium-induced damage. Food Chem Toxicol. 2011; 49:2618-2623.
43. Li W, Zhu S, Li J, Assa A, Jundoria A, Xu J, Fan S, Eissa NT, Tracey KJ, Sama AE and Wang H. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochemical pharmacology. 2011; 81:1152-1163.
44. Kim HS, Montana V, Jang HJ, Parpura V and Kim JA. Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation. The Journal of biological chemistry. 2013; 288:22693-22705.
45. Zhang Y, Yang ND, Zhou F, Shen T, Duan T, Zhou J, Shi Y, Zhu XQ and Shen HM. (-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization. PloS one. 2012; 7:e46749.
46. O'Donovan CN, Tobin D and Cotter TG. Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. The Journal of biological chemistry. 2001; 276:43516-43523.
47. Gomes AP, Duarte FV, Nunes P, Hubbard BP, Teodoro JS, Varela AT, Jones JG, Sinclair DA, Palmeira CM and Rolo AP. Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochim Biophys Acta. 2012; 1822:185-195.
48. Bai Y, Li Q, Yang J, Zhou X, Yin X and Zhao D. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells. Neurosci Res. 2008; 62:9-14.
49. Forloni G, Bugiani O, Tagliavini F and Salmona M. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. Mol Chem Neuropathol. 1996; 28:163-171.
50. Wang Y, Musich PR, Serrano MA, Zou Y, Zhang J and Zhu MY. Effects of DSP4 on the Noradrenergic Phenotypes and Its Potential Molecular Mechanisms in SH-SY5Y Cells. Neurotoxicity research. 2013.
51. Zhan Q, Tsai S, Lu Y, Wang C, Kwan Y and Ngai S. RuvBL2 is involved in histone deacetylase inhibitor PCI-24781-induced cell death in SK-N-DZ neuroblastoma cells. PloS one. 2013; 8:e71663.
52. Hasegawa K and Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2008; 28:8772-8784.
53. Hernandez-Jimenez M, Hurtado O, Cuartero MI, Ballesteros I, Moraga A, Pradillo JM, McBurney MW, Lizasoain I and Moro MA. Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke; a journal of cerebral circulation. 2013; 44:2333-2337.
54. Lam WH, Kazi A, Kuhn DJ, Chow LM, Chan AS, Dou QP and Chan TH. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]. Bioorg Med Chem. 2004; 12:5587-5593.
55. Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH and Wong YC. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Nutr Cancer. 2008; 60:483-491.
56. Hudson SA, Ecroyd H, Dehle FC, Musgrave IF and Carver JA. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway. Journal of molecular biology. 2009; 392:689-700.
57. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD and Tan J. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain research. 2008; 1214:177-187.
58. Chung WG, Miranda CL and Maier CS. Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells. Brain Res. 2007; 1176:133-142.
59. Levites Y, Weinreb O, Maor G, Youdim MB and Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineinduced dopaminergic neurodegeneration. J Neurochem. 2001; 78:1073-1082.
60. Levites Y, Youdim MB, Maor G and Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factorkappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol. 2002; 63:21-29.
61. Wang L, Xu S, Xu X and Chan P. (-)-Epigallocatechin-3-Gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation. J Alzheimers Dis. 2009; 17:295-304.
62. Rambold AS, Miesbauer M, Olschewski D, Seidel R, Riemer C, Smale L, Brumm L, Levy M, Gazit E, Oesterhelt D, Baier M, Becker CF, Engelhard M, Winklhofer KF and Tatzelt J. Green tea extracts interfere with the stressprotective activity of PrP and the formation of PrP. Journal of neurochemistry. 2008; 107:218-229.
63. Lee SR, Kim SP and Kim JE. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci Lett. 2000; 281:183-186.
64. Perron NR and Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys. 2009; 53:75-100.
65. Lin LC, Wang MN, Tseng TY, Sung JS and Tsai TH. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. Journal of agricultural and food chemistry. 2007; 55:1517-1524.
66. Devika PT and Stanely Mainzen Prince P. (-) Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic and in vitro study. Pharmacol Res. 2008; 57:351-357.
67. Tao L, Forester SC and Lambert JD. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells. Molecular nutrition & food research. 2013.
68. Satoh M, Takemura Y, Hamada H, Sekido Y and Kubota S. EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy. Cancer cell international. 2013; 13:19.
69. Gao Y, Li W, Jia L, Li B, Chen YC and Tu Y. Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways. Biochemical and biophysical research communications. 2013; 438:370-374.
70. Tai KK and Truong DD. (-)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyltrichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells. Neuroscience letters. 2010; 482:183-187.
71. Levites Y, Amit T, Youdim MB and Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. The Journal of biological chemistry. 2002; 277:30574-30580.
72. Yu Y, Shiou SR, Guo Y, Lu L, Westerhoff M, Sun J, Petrof EO and Claud EC. Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitis. PloS one. 2013; 8:e69620.
73. Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M and Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy. 2005; 1:131-140.
74. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H and Neri C. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet. 2005; 37:349-350.
75. Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem. 2006; 281:21745-21754.
76. Seo JS, Moon MH, Jeong JK, Seol JW, Lee YJ, Park BH and Park SY. SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death. Neurobiology of aging. 2012; 33:1110-1120.
77. Mudo G, Makela J, Di Liberto V, Tselykh TV, Olivieri M, Piepponen P, Eriksson O, Malkia A, Bonomo A, Kairisalo M, Aguirre JA, Korhonen L, Belluardo N and Lindholm D. Transgenic expression and activation of PGC-1alpha protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cell Mol Life Sci. 2012; 69:1153-1165.
78. Ettaiche M, Pichot R, Vincent JP and Chabry J. In vivo cytotoxicity of the prion protein fragment 106-126. The Journal of biological chemistry. 2000; 275:36487-36490.